BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7854199)

  • 1. Stimulation of the autophagic activity in blastospores of Candida albicans exposed in vitro to fluconazole.
    Pancaldi S; Dall'Olio G; Poli F; Fasulo MP
    Microbios; 1994; 80(322):55-61. PubMed ID: 7854199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of monensin on chitin synthesis in Candida albicans blastospores.
    Poli F; Pancaldi S; Vannini GL
    Eur J Cell Biol; 1986 Oct; 42(1):79-83. PubMed ID: 3539611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural investigations of the formation of Candida albicans germ tubes and septa.
    Scherwitz C; Martin R; Ueberberg H
    Sabouraudia; 1978 Jun; 16(2):115-24. PubMed ID: 358432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular distribution and antifungal effects of fluconazole in human phagocytic cells. Demonstration of the antifungal agent in neutrophil polymorphonuclear leucocytes and monocytes by autoradiography and electron micrography.
    Wildfeur A; Reisert I; Laufen H
    Arzneimittelforschung; 1992 Aug; 42(8):1049-52. PubMed ID: 1418080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
    Wildfeuer A; Seidl HP
    Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of PDE2, the gene encoding the high-affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicans.
    Jung WH; Warn P; Ragni E; Popolo L; Nunn CD; Turner MP; Stateva L
    Yeast; 2005 Mar; 22(4):285-94. PubMed ID: 15789349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.
    Pfaller M; Riley J
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):152-6. PubMed ID: 1396728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage of Candida albicans blastoconidia exposed to biocides.
    Kurzaątkowski W; Staniszewska M; Tyski S
    Mycoses; 2011 Sep; 54(5):e286-93. PubMed ID: 20492534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 prime].
    Wang YB; Wang H; Guo HY; Zhao YZ; Luo SQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1303-6. PubMed ID: 14678897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions of fluconazole and phagocytic cells].
    Wildfeuer A; Laufen H; Haferkamp O
    Mycoses; 1991; 34 Suppl 1():53-7. PubMed ID: 1818264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin.
    Cateau E; Levasseur P; Borgonovi M; Imbert C
    Clin Microbiol Infect; 2007 Mar; 13(3):311-5. PubMed ID: 17391387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans switch phenotypes display differential levels of fitness.
    Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
    Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J; Subik J
    Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 8-methoxypsoralen plus 365 nm UVA light on Candida albicans cells. An electron microscopic study.
    Scherwitz C; Rassner G; Martin R
    Arch Dermatol Res; 1978; 263(1):47-58. PubMed ID: 394689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.